Exodus Point Capital Management, LP Vera Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 153,596 shares of VERA stock, worth $7.53 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
153,596
Previous 41,917
266.43%
Holding current value
$7.53 Million
Previous $1.52 Million
347.53%
% of portfolio
0.04%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
181Shares Held
55.1MCall Options Held
101KPut Options Held
110K-
Avoro Capital Advisors LLC New York, NY4.31MShares$211 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$193 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$164 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$145 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$137 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.33B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...